Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,521 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Are resting metabolic rate and clinical symptoms affected by variation of serum thyroid stimulating hormone levels within the normal range in healthy and women with hypothyroidism? A case-control study.
Harsini AR, Mohajeri-Tehrani MR, Sajjadi-Jazi SM, Naeini F, Valisoltani N, Sadeghi E, Mohammadi H, Hosseini S. Harsini AR, et al. Among authors: hosseini s. Clin Nutr ESPEN. 2024 Jun;61:71-78. doi: 10.1016/j.clnesp.2024.02.030. Epub 2024 Mar 13. Clin Nutr ESPEN. 2024. PMID: 38777475
Development, comparison, and internal validation of prediction models to determine the visual prognosis of patients with open globe injuries using machine learning approaches.
Shariati MM, Eslami S, Shoeibi N, Eslampoor A, Sedaghat M, Gharaei H, Zarei-Ghanavati S, Derakhshan A, Abrishami M, Abrishami M, Hosseini SM, Rad SS, Astaneh MA, Farimani RM. Shariati MM, et al. Among authors: hosseini sm. BMC Med Inform Decis Mak. 2024 May 21;24(1):131. doi: 10.1186/s12911-024-02520-4. BMC Med Inform Decis Mak. 2024. PMID: 38773484 Free PMC article.
The effect of soy isoflavones supplementation on metabolic status in patients with non-alcoholic fatty liver disease: a randomized placebo controlled clinical trial.
Neshatbini Tehrani A, Hatami B, Daftari G, Hekmatdoost A, Yari Z, Salehpour A, Hosseini SA, Helli B. Neshatbini Tehrani A, et al. Among authors: hosseini sa. BMC Public Health. 2024 May 21;24(1):1362. doi: 10.1186/s12889-024-18812-3. BMC Public Health. 2024. PMID: 38773414 Free PMC article. Clinical Trial.
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial.
Coutts SB, Ankolekar S, Appireddy R, Arenillas JF, Assis Z, Bailey P, Barber PA, Bazan R, Buck BH, Butcher KS, Camden MC, Campbell B, Casaubon LK, Catanese L, Chatterjee K, Choi PMC, Clarke B, Dowlatshahi D, Ferrari J, Field TS, Ganesh A, Ghia D, Goyal M, Greisenegger S, Halse O, Horn M, Hunter G, Imoukhuede O, Kelly PJ, Kennedy J, Kenney C, Kleinig TJ, Krishnan K, Lima F, Mandzia JL, Marko M, Martins SO, Medvedev G, Menon BK, Mishra SM, Molina C, Moussaddy A, Muir KW, Parsons MW, Penn AMW, Pille A, Pontes-Neto OM, Roffe C, Serena J, Simister R, Singh N, Spratt N, Strbian D, Tham CH, Wiggam MI, Williams DJ, Willmot MR, Wu T, Yu AYX, Zachariah G, Zafar A, Zerna C, Hill MD; TEMPO-2 investigators. Coutts SB, et al. Lancet. 2024 May 16:S0140-6736(24)00921-8. doi: 10.1016/S0140-6736(24)00921-8. Online ahead of print. Lancet. 2024. PMID: 38768626
3,521 results